Beijing Health (Holdings) Beheer

Beheer criteriumcontroles 4/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Xue Heng Liu

Algemeen directeur

HK$930.0k

Totale compensatie

Percentage CEO-salaris	91.6%
Dienstverband CEO	2.3yrs
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	8.8yrs
Gemiddelde ambtstermijn bestuur	10.2yrs

Recente managementupdates

Recent updates

Here's Why We're Not Too Worried About Beijing Health (Holdings)'s (HKG:2389) Cash Burn Situation

Sep 05

Beijing Health (Holdings) (HKG:2389) Is In A Good Position To Deliver On Growth Plans

Mar 01

Companies Like Beijing Health (Holdings) (HKG:2389) Are In A Position To Invest In Growth

Sep 12

Is Beijing Enterprises Medical and Health Industry Group (HKG:2389) Using Too Much Debt?

Dec 15

Analyse CEO-vergoeding

Hoe is Xue Heng Liu's beloning veranderd ten opzichte van Beijing Health (Holdings)'s winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	-HK$102m
Mar 31 2024	n/a	n/a	-HK$82m
Dec 31 2023	HK$930k	HK$852k	-HK$62m
Sep 30 2023	n/a	n/a	-HK$71m
Jun 30 2023	n/a	n/a	-HK$81m
Mar 31 2023	n/a	n/a	-HK$89m
Dec 31 2022	HK$930k	HK$852k	-HK$98m
Sep 30 2022	n/a	n/a	-HK$79m
Jun 30 2022	n/a	n/a	-HK$60m
Mar 31 2022	n/a	n/a	-HK$50m
Dec 31 2021	HK$2m	HK$2m	-HK$39m
Sep 30 2021	n/a	n/a	-HK$81m
Jun 30 2021	n/a	n/a	-HK$122m
Mar 31 2021	n/a	n/a	-HK$154m
Dec 31 2020	HK$1m	HK$1m	-HK$185m
Sep 30 2020	n/a	n/a	-HK$311m
Jun 30 2020	n/a	n/a	-HK$438m
Mar 31 2020	n/a	n/a	-HK$430m
Dec 31 2019	HK$2m	HK$2m	-HK$422m
Sep 30 2019	n/a	n/a	-HK$215m
Jun 30 2019	n/a	n/a	-HK$8m
Mar 31 2019	n/a	n/a	HK$18m
Dec 31 2018	HK$5m	HK$2m	HK$43m
Sep 30 2018	n/a	n/a	HK$152m
Jun 30 2018	n/a	n/a	HK$261m
Mar 31 2018	n/a	n/a	HK$237m
Dec 31 2017	HK$7m	HK$2m	HK$214m

Compensatie versus markt: De totale vergoeding ($USD 119.63K ) Xue Heng } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 233.89K ).

Compensatie versus inkomsten: De vergoeding van Xue Heng is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Xue Heng Liu (51 yo)

2.3yrs

Tenure

HK$930,000

Compensatie

Mr. Xue Heng Liu has been Executive Chairman and Chief Executive Officer at Beijing Sports and Entertainment Industry Group Limited (formerly ASR Logistics Holdings Limited) since January 25, 2016. Mr. Liu...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Shi Xing Zhu	Executive Chairman of the Board	10.2yrs	HK$2.80m	geen gegevens
Xue Heng Liu	CEO & Executive Director	2.3yrs	HK$930.00k	geen gegevens
Zheng Chun Wang	Executive Director	no data	HK$60.00k	1.74% HK$ 9.0m
Kin Wai Siu	Executive Director	7.5yrs	HK$60.00k	geen gegevens
Shan Chao Gu	Executive Director	10.2yrs	HK$2.28m	geen gegevens
Ka Tak Lam	CFO, Financial Controller & Company Secretary	14.2yrs	geen gegevens	geen gegevens

8.8yrs

Gemiddelde duur

54yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 2389 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 8.8 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Shi Xing Zhu	Executive Chairman of the Board	10.2yrs	HK$2.80m	geen gegevens
Xue Heng Liu	CEO & Executive Director	10.2yrs	HK$930.00k	geen gegevens
Zheng Chun Wang	Executive Director	16.4yrs	HK$60.00k	1.74% HK$ 9.0m
Kin Wai Siu	Executive Director	7.5yrs	HK$60.00k	geen gegevens
Shan Chao Gu	Executive Director	10.2yrs	HK$2.28m	geen gegevens
Man Kit Tse	Independent Non-Executive Director	10.2yrs	HK$60.00k	geen gegevens
Yong Xin Wu	Independent Non-Executive Director	10.2yrs	HK$60.00k	geen gegevens
Yun Zhou Zhang	Independent Non-Executive Director	9.5yrs	HK$60.00k	geen gegevens

10.2yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 2389 zijn ervaren en ervaren (gemiddelde ambtstermijn van 10.2 jaar).

Beijing Health (Holdings) Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Beijing Health (Holdings) Limited Announces Management Changes

Less than half of directors are independent

Beijing Health (Holdings) Limited Announces Resignation of Zhang Jing Ming as Executive Director

Less than half of directors are independent

Beijing Health (Holdings) Limited, Annual General Meeting, May 30, 2022

Recent updates

Here's Why We're Not Too Worried About Beijing Health (Holdings)'s (HKG:2389) Cash Burn Situation

Beijing Health (Holdings) Limited to Report First Half, 2024 Results on Aug 29, 2024

Full year 2023 earnings released: HK$0.01 loss per share (vs HK$0.016 loss in FY 2022)

Beijing Health (Holdings) Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Beijing Health (Holdings) (HKG:2389) Is In A Good Position To Deliver On Growth Plans

Beijing Health (Holdings) Limited Announces Management Changes

Beijing Health (Holdings) Limited to Report First Half, 2023 Results on Sep 21, 2023

Companies Like Beijing Health (Holdings) (HKG:2389) Are In A Position To Invest In Growth

First half 2023 earnings released: HK$0.003 loss per share (vs HK$0.005 loss in 1H 2022)

Beijing Health (Holdings) Limited to Report First Half, 2023 Results on Aug 29, 2023

Now 20% undervalued

Full year 2022 earnings released: HK$0.016 loss per share (vs HK$0.006 loss in FY 2021)

Now 26% undervalued

A Look At The Fair Value Of Beijing Health (Holdings) Limited (HKG:2389)

Less than half of directors are independent

Health Check: How Prudently Does Beijing Health (Holdings) (HKG:2389) Use Debt?

First half 2022 earnings released: HK$0.005 loss per share (vs HK$0.002 loss in 1H 2021)

Beijing Health (Holdings) Limited Announces Resignation of Zhang Jing Ming as Executive Director

Is Beijing Health (Holdings) (HKG:2389) Using Debt In A Risky Way?

Less than half of directors are independent

Beijing Health (Holdings) Limited, Annual General Meeting, May 30, 2022

Full year 2021 earnings released: HK$0.006 loss per share (vs HK$0.03 loss in FY 2020)

Beijing Health (Holdings) Limited to Report Fiscal Year 2021 Results on Mar 30, 2022

Now 24% undervalued after recent price drop

Now 24% undervalued after recent price drop

First half 2021 earnings released: HK$0.002 loss per share (vs HK$0.012 loss in 1H 2020)

Full year 2020 earnings released: HK$0.03 loss per share (vs HK$0.07 loss in FY 2019)

Beijing Enterprises Medical and Health Industry Group Limited to Report Fiscal Year 2020 Results on Mar 30, 2021

Is Beijing Enterprises Medical and Health Industry Group (HKG:2389) Using Too Much Debt?

Beijing Enterprises Medical and Health Industry Group Limited to Report First Half, 2020 Results on Sep 17, 2020

Beijing Enterprises Medical and Health Industry Group Limited(SEHK:2389) dropped from S&P Global BMI Index

First half earnings released

First half earnings released

Beijing Enterprises Medical and Health Industry Group Limited to Report First Half, 2020 Results on Aug 28, 2020

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd